Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geovax Labs (NQ: GOVX )

2.330 +0.440 (+23.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,447,981
Open 1.710
Bid (Size) 2.420 (10)
Ask (Size) 2.440 (8)
Prev. Close 1.890
Today's Range 1.691 - 2.490
52wk Range 0.2500 - 4.330
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
Exposures Death
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Performance

YTD
+529.73%
+529.73%
1 Month
+44.72%
+44.72%
3 Month
+20.73%
+20.73%
6 Month
+573.41%
+573.41%
1 Year
+279.17%
+279.17%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
GeoVax to Present at BIO International Convention 2024
Via TheNewswire.com
Exposures COVID-19
GeoVax to Present Data on GEO-CM04S1, A Next Generation Covid-19 Vaccine, at the World Vaccine Congress
Via NewMediaWire
Exposures COVID-19
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
From FN Media Group LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
Via NewMediaWire
Exposures COVID-19
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
GeoVax to Present at BIO International Convention 2024
Via NewMediaWire
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
GOVX Stock Earnings: Geovax Labs Beats EPS for Q1 2024
Via InvestorPlace
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Via TheNewswire.com
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Via NewMediaWire
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
Via NewMediaWire
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
Via TheNewswire.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
Via NewMediaWire
Exposures COVID-19
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
Via TheNewswire.com
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.